anti-CTLA-4 (ipilimumab)
- Quality Assurance. Produced with rigorous standards to ensure very low endotoxin levels, consistency, and reliability.
- Extensive Range. A broad spectrum of isotype controls tailored to various species and subclasses.
- Expert Guidance. Support from our team in selecting appropriate isotype controls for specific experimental needs.
Product specifications
| Species | Human |
|---|---|
| Isotype | IgG1 |
| Mutation | K214R |
| Concentration | 5 mg/mL |
| Formulation | Dulbecco's PBS (pH 7.2-7.4) |
| Purity | 99.8 % SEC, initial release |
Related products
Place your order
Send us your order, and we will contact you promptly with delivery and payment details.
View Quote items in your quote